Management of localized seminoma, stage I-II: SIU/ICUD consensus meeting on germ cell tumors (GCT), Shanghai 2009

Urology

Volumn 78, Issue 4 SUPPL., 2011, Pages

  Warde, P ^a   Huddart, R ^b   Bolton, D ^c   Heidenreich, A ^d   Gilligan, T ^e   Fossa, S ^f  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^e Department of Solid Tumor Oncology   (United States)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CARBOPLATIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CREATININE; LACTATE DEHYDROGENASE;

AREA UNDER THE CURVE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CREATININE CLEARANCE; DISEASE SURVEILLANCE; DOSE CALCULATION; ECHOGRAPHY; FOLLOW UP; FROZEN SECTION; GLOMERULUS FILTRATION RATE; HALF LIFE TIME; HUMAN; IONIZING RADIATION; MALE GENITAL SYSTEM EXAMINATION; MULTIPLE CYCLE TREATMENT; ORCHIECTOMY; PARAAORTIC LYMPH NODE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RADIATION CARCINOGENESIS; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPEAT PROCEDURE; RETE TESTIS; RETROPERITONEAL CANCER; SALVAGE THERAPY; SCROTUM; SECOND CANCER; SEMINOMA; SURVIVAL RATE; TESTIS BIOPSY; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

CHINA; COMBINED MODALITY THERAPY; HUMANS; MALE; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; SEMINOMA; TESTICULAR NEOPLASMS;

EID: 80054768611     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2011.02.031     Document Type: Conference Paper

References (61)

1. D.M. Parkin, F. Bray, and J. Ferlay Global Cancer Statistics 2002 CA Cancer J Clin 55 2005 74 108
2. M.P. Purdue, S.S. Devesa, and A.J. Sigurdson International patterns and trends in testis cancer incidence Int J Cancer 115 2005 822 827 (Pubitemid 40776707)
3. L. Collette, R.J. Sylvester, and S.P. Stenning Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working Party J Natl Cancer Inst 91 1999 839 846
4. R. Huddart, and V. Kataja Testicular seminoma: ESMO clinical recommendations for diagnosis, treatment and follow-up Ann Oncol 19 suppl 2 2008 ii49 ii51
5. S. Krege, J. Beyer, and R. Souchon European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I Eur Urol 53 2008 478 496
6. S. Krege, J. Beyer, and R. Souchon European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II Eur Urol 53 2008 497 513
7. L. Wood, C. Kollmannsberger, and M. Jewett Canadian consensus guidelines for the management of testicular germ cell cancer Can Urol Assoc J 4 2010 e19 e38
8. P. Abrams, S. Khoury, and A. Grant Evidence-based medicine overview of the main steps for developing and grading guideline recommendations Prog Urol 17 2007 681 684
9. G.A. Whitfield, G. Horan, and M.M. Daly CT chest is a waste of resources in the staging of seminoma of the testis Clin Oncol R Coll Radiol 19 3 Suppl 2007 S31 S32
10. M. de Wit, W. Brenner, and M. Hartmann [18F]-FDG-PET in clinical stage I/II non-seminomatous germ cell tumours: results of the German multicentre trial Ann Oncol 19 2008 1619 1623
11. S.A. Sohaib, D.M. Koh, and Y. Barbachano Prospective assessment of MRI for imaging retroperitoneal metastases from testicular germ cell tumours Clin Radiol 64 2009 362 367
12. L.H. Sobin, M.K. Gospodarowicz, and C. Wittekind UICC-TNM Classification of Malignant Tumours 7th ed. 2009 John Wiley & Sons New York
13. A.M. Winstanley, G. Mikuz, and F. Debruyne Handling and reporting of biopsy and surgical specimens of testicular cancer Eur Urol 45 2004 564 573 (Pubitemid 38481682)
14. G.K. Zagars, M.T. Ballo, and A.K. Lee Mortality after cure of testicular seminoma J Clin Oncol 22 2004 640 647 (Pubitemid 41095067)
15. F.E. van Leeuwen, A.M. Stiggelbout, and A.W. van den Belt-Dusebout Second cancer risk following testicular cancer: a follow-up study of 1,909 patients J Clin Oncol 11 1993 415 424 (Pubitemid 23071036)
16. A.W. van den Belt-Dusebout, R. de Wit, and J.A. Gietema Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer J Clin Oncol 25 2007 4370 4378 (Pubitemid 350013842)
17. A.W. van den Belt-Dusebout, J. Nuver, and R. de Wit Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer J Clin Oncol 24 2006 467 475 (Pubitemid 46630466)
18. L.B. Travis, S.D. Fossa, and S.J. Schonfeld Second cancers among 40,576 testicular cancer patients: focus on long-term survivors J Natl Cancer Inst 97 2005 1354 1365 (Pubitemid 41487803)
19. R.A. Huddart, A. Norman, and M. Shahidi Cardiovascular disease as a long-term complication of treatment for testicular cancer J Clin Oncol 21 2003 1513 1523 (Pubitemid 46594104)
20. R.T. Oliver, M.D. Mason, and G.M. Mead Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial Lancet 366 2005 293 300 (Pubitemid 41019418)
21. R. Oliver, L. Boubilkova, and J. Ong Fifteen-year follow-up of the Anglian Germ Cell Cancer group adjuvant studies of carboplatin as an alternative to radiation or surveillance for stage 1 seminoma Proc Am Soc Clin Oncol 19 2001 Abstract 780
22. J.R. Germa-Lluch, X. Garcia del Muro, and P. Maroto Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG) Eur Urol 42 2002 553 562
23. G. Daugaard, P.M. Petersen, and M. Rorth Surveillance in stage I testicular cancer APMIS 111 2003 76 83, 75
24. H. von der Maase, L. Specht, and G.K. Jacobsen Surveillance following orchidectomy for stage I seminoma of the testis Eur J Cancer 29A 1993 1931 1934 (Pubitemid 23324346)
25. P.R. Warde, P. Chung, and J. Sturgeon Should surveillance be considered the standard of care in stage I seminoma? J Clin Oncol (Meeting Abstracts) 23 16 suppl 2005 4520
26. S. Cummins, T. Yau, and R. Huddart Surveillance in stage I seminoma patients: a long-term assessment Eur Urol 57 2009 673 678
27. P. Warde, L. Specht, and A. Horwich Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis J Clin Oncol 20 2002 4448 4452 (Pubitemid 35334756)
28. J. Aparicio, J.R. Germa, and X. Garcia del Muro Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study J Clin Oncol 23 2005 8717 8723 (Pubitemid 46211516)
29. J. Oldenburg, J.M. Martin, and S.D. Fossa Late relapses of germ cell malignancies: incidence, management, and prognosis J Clin Oncol 24 2006 5503 5511 (Pubitemid 46631330)
30. N.J. van As, D.C. Gilbert, and J. Money-Kyrle Evidence-based pragmatic guidelines for the follow-up of testicular cancer: optimising the detection of relapse Br J Cancer 98 2008 1894 1902 (Pubitemid 351821555)
31. J.M. Martin, T. Panzarella, and D.R. Zwahlen Evidence-based guidelines for following stage 1 seminoma Cancer 109 2007 2248 2256 (Pubitemid 46801554)
32. S. Tolan, D. Vesprini, and M.A. Jewett No role for routine chest radiography in stage I seminoma surveillance Eur Urol 57 2009 474 479
33. R. Santoni, F. Barbera, and F. Bertoni Stage I seminoma of the testis: a bi-institutional retrospective analysis of patients treated with radiation therapy only BJU Int 92 2003 47 52 (Pubitemid 36843027)
34. W.G. Jones, S.D. Fossa, and G.M. Mead Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I testicular seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328) J Clin Oncol 23 2005 1200 1208 (Pubitemid 46202277)
35. S.D. Fossa, A. Horwich, and J.M. Russell Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial Medical Research Council Testicular Tumor Working Group J Clin Oncol 17 1999 1146
36. J.M. Coleman, R.E. Coleman, and A.R. Turner The management and clinical course of testicular seminoma: 15 years' experience at a single institution Clin Oncol R Coll Radiol 10 1998 237 241 (Pubitemid 28454543)
37. J. Classen, H. Schmidberger, and C. Meisner Para-aortic irradiation for stage I testicular seminoma: results of a prospective study in 675 patients A trial of the German testicular cancer study group (GTCSG) Br J Cancer 90 2004 2305 2311 (Pubitemid 38961892)
38. J.P. Logue, M.A. Harris, and J.E. Livsey Short course para-aortic radiation for stage I seminoma of the testis Int J Radiat Oncol Biol Phys 57 2003 1304 1309 (Pubitemid 37443969)
39. Vesprini D, Tolan S, Jewett M, et al. Evaluation of serum tumor markers to predict relapse in patients in surveillance for stage 1 seminoma. Paper presented at: 2009 Genitourinary Cancers Symposium; February 26-28, 2009; Orlando, Florida. 2009.
40. G.M. Mead, S.D. Fossa, and R.T. Oliver Relapse patterns in 2, 466 stage 1 seminoma patients (pts) entered into Medical Research Council randomised trials J Clin Oncol 26 2008 5020
41. S.D. Fossa, E. Gilbert, and G.M. Dores Noncancer causes of death in survivors of testicular cancer J Natl Cancer Inst 99 2007 533 544 (Pubitemid 47073556)
42. H. Moller, S. Friis, and S.K. Kjaer Survival of Danish cancer patients 1943-1987: male genital organs APMIS Suppl 33 1993 122 126
43. D.R. Zwahlen, J.M. Martin, and J.L. Millar Effect of radiotherapy volume and dose on secondary cancer risk in stage I testicular seminoma Int J Radiat Oncol Biol Phys 70 2008 853 858
44. K.D. Jacobsen, D.R. Olsen, and K. Fossa External beam abdominal radiotherapy in patients with seminoma stage I: field type, testicular dose, and spermatogenesis Int J Radiat Oncol Biol Phys 38 1997 95 102 (Pubitemid 27270947)
45. S. Bieri, M. Rouzaud, and R. Miralbell Seminoma of the testis: is scrotal shielding necessary when radiotherapy is limited to the para-aortic nodes? Radiother Oncol 50 1999 349 353 (Pubitemid 29207538)
46. K.P. Dieckmann, B. Bruggeboes, and U. Pichlmeier Adjuvant treatment of clinical stage I seminoma: is a single course of carboplatin sufficient? Urology 55 2000 102 106 (Pubitemid 30050766)
47. A.H. Calvert, and M.J. Egorin Carboplatin dosing formulae: gender bias and the use of creatinine-based methodologies Eur J Cancer 38 2002 11 16 (Pubitemid 34031819)
48. P.W. Chung, M.K. Gospodarowicz, and T. Panzarella Testicular seminoma: patterns of recurrence and outcome of treatment Eur Urol 45 2004 754 760 (Pubitemid 38638396)
49. Y.C. Bayens, P.A. Helle, and W.L. Van Putten Orchidectomy followed by radiotherapy in 176 stage I and II testicular seminoma patients: benefits of a 10-year follow-up study Radiother Oncol 25 1992 97 102
50. K.A. Vallis, G.C. Howard, and W. Duncan Radiotherapy for stages I and II testicular seminoma: results and morbidity in 238 patients Br J Radiol 68 1995 400 405
51. G.K. Zagars, and A. Pollack Radiotherapy for stage II testicular seminoma Int J Radiat Oncol Biol Phys 51 2001 643 649
52. J. Classen, H. Schmidberger, and C. Meisner Radiotherapy for stages IIA/B testicular seminoma: final report of a prospective multicenter clinical trial J Clin Oncol 21 2003 1101 1106 (Pubitemid 46594140)
53. D.C. Gilbert, N.J. Vanas, and S. Beesley Seminoma with combination carboplatin and radiotherapy J Clin Oncol 27 2009 2101 2103
54. A.A. Mosharafa, R.S. Foster, and B.C. Leibovich Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity? J Urol 169 2003 2126 2128 (Pubitemid 36576732)
55. K.N. Ganjoo, R.J. Chan, and M. Sharma Positron emission tomography scans in the evaluation of postchemotherapy residual masses in patients with seminoma J Clin Oncol 17 1999 3457 3460 (Pubitemid 29517915)
56. A. Becherer, M. De Santis, and G. Karanikas FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals Eur J Radiol 54 2005 284 288 (Pubitemid 40523622)
57. S. Hinz, M. Schrader, and C. Kempkensteffen The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma J Urol 179 2008 936 940
58. H.W. Herr, J. Sheinfeld, and H.S. Puc Surgery for a post-chemotherapy residual mass in seminoma J Urol 157 1997 860 862 (Pubitemid 27066267)
59. S. Culine, and J.P. Droz Optimal management of residual mass after chemotherapy in advanced seminoma: there is time for everything J Clin Oncol 14 1996 2884 2885 (Pubitemid 26329675)
60. A. Horwich, B. Paluchowska, and A. Norman Residual mass following chemotherapy of seminoma Ann Oncol 8 1997 37 40 (Pubitemid 27112800)
61. G.M. Duchesne, S.P. Stenning, and N. Aass Radiotherapy after chemotherapy for metastatic seminomaa diminishing role MRC Testicular Tumour Working Party Eur J Cancer 33 1997 829 835 (Pubitemid 27287030)